NCT04514198

Brief Summary

AIM To determine association between postoperative pancreatitis and pancreatic fistula OBJECTIVES

  1. 1.To determine incidence of Clinically relevant pancreatic fistula (grade B/C) after pancreaticoduodenectomy
  2. 2.To determine role of serum amylase levels on day 1 to predict clinically relevant pancreatic fistula
  3. 3.To determine risk factors for postoperative pancreatitis and postoperative pancreatic fistula
  4. 4.to identify the possible predictors of post operative pancreatitis.
  5. 5.to investigate the association between post operative pancreatitis and post operative pancreatic fistula.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 14, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

January 3, 2024

Status Verified

January 1, 2024

Enrollment Period

1.8 years

First QC Date

August 12, 2020

Last Update Submit

January 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • To estimate incidence of Post operative Pancreatitis and post operative pancreatic fistula among patients undergoing pancreaticoduodenectomies.

    After pancreaticoduodenectomy surgery, pancreatitis occurs it is a local inflammatory process occurring in the area of the pancreatic anastomosis after pancreas resection could induce increased systemic amylase concentration, Amylase normal range is 28--100, if it exceeds the upper normal limits it leads to post operative pancreatitis, pancreatic fistula is defined as persistent drainage of amylase rich fluid (3x \> than upper limit of normal serum amylase) for greater than 3 days.

    10 days

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Sample size : Required 35 subjects

You may qualify if:

  • All patients (\>18 yrs) undergoing elective Whipple's PD in Asian institute of gastroenterology, Hyderabad, Telangana.

You may not qualify if:

  • On table inoperable patients
  • Patients in cholangitis or bilirubin \> 15 mg/dl
  • Patients not giving consent for participation
  • Patients with acute inflammatory states (cholangitis, sepsis, trauma, acute on chronic pancreatitis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asian Institute of Gastroenterology/AIG Hospitals

Hyderabad, Telangana, 500082, India

Location

Related Publications (1)

  • Shasheendra Y, Ahmed Z, Shetty MG, Hazarathaiah N, Rebala P, Rao GV. Association of Postoperative Hyperamylasemia With Clinically Relevant Postoperative Pancreatic Fistula in Pancreatoduodenectomy. Cureus. 2024 Jan 30;16(1):e53257. doi: 10.7759/cureus.53257. eCollection 2024 Jan.

MeSH Terms

Conditions

Pancreatic Diseases

Condition Hierarchy (Ancestors)

Digestive System Diseases

Study Officials

  • Dr Pradeep Rebala, MBBS MS MCH

    Asian Institute of Gastroenterology, India

    STUDY CHAIR
  • Dr Shasheendra yanagandula, MBBS MS

    Asian Institute of Gastroenterology, India

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

August 12, 2020

First Posted

August 14, 2020

Study Start

March 1, 2020

Primary Completion

January 1, 2022

Study Completion

March 1, 2022

Last Updated

January 3, 2024

Record last verified: 2024-01

Locations